RalphRWeichselbaumMD

Radiation Oncology • Chicago, IL

D.K. Ludwig Professor of Rad and Cellular Oncology, University of Chicago Medicine

Join to view full profile

Dr. Weichselbaum is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Weichselbaum's full profile

Already have an account?

Office
5758 S Maryland Ave
Mc9006
Chicago, IL 60637
Phone+1 773-702-0817

Fax+1 773-834-7233

Education & Training

Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Radiation Oncology, 1972 - 1975
Alameda Health System-Highland HospitalInternship, Internal Medicine, 1971 - 1972
University of Illinois College of MedicineClass of 1971

Certifications & Licensure

CA State Medical License 1973 - Present
IL State Medical License 1984 - 2026
MA State Medical License 1972 - 2009
American Board of Radiology Therapeutic Radiology

Awards, Honors, & Recognition

Elected Member Institute of Medicine, 1997
Super Doctor SuperDoctors.com

Publications & Presentations

PubMed

Pushing the boundaries of radiotherapy-immunotherapy combinations: highlights from the 7immunorad conference.
Pierre-Antoine Laurent, Fabrice André, Alexandre Bobard, Desiree Deandreis, Sandra Demaria
Oncoimmunology. 2025-12-01
Nanoscale Mixed-Ligand Metal-Organic Framework for X-ray Stimulated Cancer Therapy.
Wenyao Zhen, Ziwan Xu, Yibin Mao, Caroline McCleary, Xiaomin Jiang
Journal of the American Chemical Society. 2024-12-04
YTHDF1 loss in dendritic cells potentiates radiation-induced antitumor immunity via STING-dependent type I IFN production.
Chuangyu Wen, Liangliang Wang, András Piffkó, Dapeng Chen, Xianbin Yu
The Journal of Clinical Investigation. 2024-12-02

Journal Articles

The Change of Soluble Programmed Cell Death-Ligand 1 in Glioma Patients Receiving Radiotherapy and Its Impact on Clinical Outcomes
Ralph Weichselbaum, MD, Frontiers in Immunology
Classification for Long-Term Survival in Oligometastatic Patients Treated with Ablative Radiotherapy: A Multi-Institutional Pooled Analysis
Julian C Hong, A William Blackstock, Joseph K Salama, Paul Okunieff, Michael T Milano, James J Urbanic, Ralph R Weichselbaum, Johnny Kao, Max W Sung, Steven J Chmura, PLoS One

Press Mentions

UChicago Medicine Names Radiation Oncology LeaderDecember 6th, 2024
Ralph Weichselbaum, MD, Appointed University of Chicago Health System Leader for Radiation and Cellular OncologyDecember 4th, 2024
Ludwig Chicago Nanotechnology Induces Therapeutic Immune Responses Against Multiple Types of TumorsOctober 29th, 2022
Join now to see all

Grant Support

P-3: Radiation Inducible Tnf-A Therapy For Prostate CancerNational Cancer Institute2011–2012
Radiation Enhancement Of HSV Anti-Tumor EffectsNational Cancer Institute2009–2011
P-3: Radiation Inducible Tnf-A Therapy For Prostate CancerNational Cancer Institute2010
Radiation Inducible Tnf-A Therapy For Prostate CancerNational Cancer Institute2009
Mechanisms Of Resistance To Radio Inducible Gene TherapyNational Cancer Institute2005–2009
DNA Damage Targeted Gene Therapy In Head &Neck CancerNational Cancer Institute2005–2009
Gene Therapy For Extension Of Vein Graft PatencyNational Heart, Lung, And Blood Institute2003–2005
Design Of Genetically Engineered HSV For Cancer TherapyNational Cancer Institute1997–2001
Training Program In Environmental Biology (NRSA)National Cancer Institute1993–2000
Pilot--Gene Therapy In Oral CancersNational Institute Of Dental &Craniofacial Research1996–1999
Novel Methods Of Tumor Cell RadiosensitizationNational Cancer Institute1995–1998
3D Dose Escalation For Prostate CancerNational Cancer Institute1994–1996
Radiation Gene Induction--Applications To Gene TargetingNational Cancer Institute1993–1995
Assays Of Tumor Response To RadiotherapyNational Cancer Institute1986–1994
3-Dose Escalation Study For Prostate CancerNational Cancer Institute1993
X-RAY &Molecular Probes Of RetinoblastomaNational Cancer Institute1988–1992
Environmental BiologyNational Cancer Institute1988–1992
X-RAY And Molecular Probes Of RetinoblastomaNational Cancer Institute1988–1990
Training Program In Environmental BiologyNational Cancer Institute1986–1987